Cargando…
Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy
BACKGROUND: The detailed treatment regimen of COVID-19 patients with hematological malignancies has been unclear, and some fatalities have occurred, although combination therapy with antiviral agents and corticosteroids has been established for moderate to severe COVID-19 patients. CASE SERIES: Case...
Autores principales: | Seki, Masafumi, Hashimoto, Kosuke, Kondo, Nami, Ohya, Yoshitaka, Kotajima, Futoshi, Mitsutake, Kotaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733686/ https://www.ncbi.nlm.nih.gov/pubmed/36506836 http://dx.doi.org/10.2147/IDR.S393198 |
Ejemplares similares
-
Fusariosis in patients with hematological malignancies: Two case reports
por: Raymakers, Jord W., et al.
Publicado: (2023) -
Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies
por: Kuter, David J.
Publicado: (2022) -
Radiotheranostic Agents in Hematological Malignancies
por: Caers, Jo, et al.
Publicado: (2022) -
COVID-19 and Listeria Meningitis Treated by Ampicillin, Sulfamethoxazole/Trimethoprim and Meropenem
por: Seki, Masafumi, et al.
Publicado: (2023) -
Neuroleptic Malignant Syndrome Improved with Intramuscular Administration of the Anticholinergic Agent, Biperiden
por: Nisijima, Koichi
Publicado: (2023)